Evaluation of Safety Profile of Rituximab plus Lenalidomide Protocol in Frail Elderly Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients

被引：0
|
作者：
Sevgili, Bahar [1 ]
Pashayev, Tural [2 ]
Bozer, Denis Sabriye [1 ]
Gunes, Ajda [1 ]
Karacadag, Fatma Keklik [3 ]
Saydam, Guray [1 ]
机构：
[1] Ege Univ, Dept Hematol, Fac Med, Izmir, Turkiye
[2] Liv Bona Dea Hosp, Dept Hematol, Baku, Azerbaijan
[3] Tepecik Res & Educ Hosp, Dept Hematol, Istanbul, Turkiye
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
relapsed or refractory; diffuse large B-cell lymphoma; partial response; case;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ABCL-152
引用
收藏
页码：S420 / S421
页数：2
相关论文
共 50 条
  • [21] Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Ohmachi, Ken
    Niitsu, Nozomi
    Uchida, Toshiki
    Kim, Seok Jin
    Ando, Kiyoshi
    Takahashi, Naoki
    Takahashi, Naoto
    Uike, Naokuni
    Eom, Hyeon Seok
    Chae, Yee Soo
    Terauchi, Takashi
    Tateishi, Ukihide
    Tatsumi, Mitsuaki
    Kim, Won Seog
    Tobinai, Kensei
    Suh, Cheolwon
    Ogura, Michinori
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (17) : 2103 - +
  • [22] Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world
    Vodicka, Prokop
    Benesova, Katerina
    Janikova, Andrea
    Prochazka, Vit
    Belada, David
    Mocikova, Heidi
    Steinerova, Katerina
    Duras, Juraj
    Karban, Josef
    Hanackova, Veronika
    Sykorova, Alice
    Obr, Ales
    Trneny, Marek
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (02) : 162 - 165
  • [23] A COMBINATION OF LENALIDOMIDE AND RITUXIMAB AS SALVAGE THERAPY IN ELDERLY PATIENTS AFFECTED BY DIFFUSE LARGE B CELLS LYMPHOMA RELAPSED AND REFRACTORY
    Gini, G.
    Bocci, C.
    Sampaolo, M.
    Trappolini, S.
    Cacciagiu, S.
    Olivieri, J.
    Olivieri, A.
    Offidani, M.
    Rupoli, S.
    Poloni, A.
    Scortechini, A. R.
    Capelli, D.
    Montanari, M.
    Scortechini, I.
    Leoni, P.
    HAEMATOLOGICA, 2015, 100 : 145 - 145
  • [24] Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
    Mondello, Patrizia
    Steiner, Normann
    Willenbacher, Wolfgang
    Ferrero, Simone
    Ghione, Paola
    Marabese, Alessandra
    Pitini, Vincenzo
    Cuzzocrea, Salvatore
    Mian, Michael
    ONCOLOGIST, 2016, 21 (09): : 1107 - 1112
  • [25] Lenalidomide Plus Rituximab for Relapsed or Refractory Diffuse Large B-Cell, Follicular and Transformed Lymphoma: Final Data Analysis of a Phase 2 Trial
    Wang, Yucai
    Wagner-Bartak, Nicolaus
    Zhou, Shouhao
    Fowler, Nathan
    Dela Rosa, Maria Lourdes
    Zhao, Donglu
    Romaguera, Jorge E.
    Neelapu, Sattva S.
    Hagemeister, Fredrick B.
    Fanale, Michelle A.
    Oki, Yasuhiro
    Shah, Jatin J.
    Thomoas, Sheeba K.
    Hosing, Chitra M.
    Zhang, Liang
    Badillo, Maria
    Chen, Wendy
    Cai, Qingqing
    Zou, Dehui
    Champlin, Richard E.
    Fayad, Luis E.
    Lee, Hun Ju
    Wang, Michael
    BLOOD, 2015, 126 (23)
  • [26] ESHAP Versus Rituximab-ESHAP in Frail Patients With Refractory Diffuse Large B-Cell Lymphoma
    Aviles, Agustin
    Neri, Natividad
    Huerta-Guzman, Judith
    de Jesus Nambo, Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (02): : 125 - 128
  • [27] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [28] Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma
    Lee, Yong-Pyo
    Hong, Jung Yong
    Yoon, Sang Eun
    Cho, Junhun
    Shim, Joon-Ho
    Bang, Yeonghak
    Kim, Won Seog
    Kim, Seok Jin
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4241 - 4250
  • [29] Phase III trial of bendamustine plus rituximab for relapsed or refractory diffuse large B-cell lymphoma in Japan
    Kiguchi, Toru
    Terui, Yasuhito
    Izutsu, Koji
    Kameoka, Yoshihiro
    Hidaka, Michihiro
    Kato, Harumi
    Matsumura, Itaru
    Kuroda, Junya
    Ishizawa, Kenichi
    Ichikawa, Satoshi
    Ando, Kiyoshi
    Ogura, Michinori
    Tobinai, Kensei
    Fukushima, Koji
    Murayama, Kayoko
    ANNALS OF ONCOLOGY, 2021, 32 : S304 - S304
  • [30] Polatuzumab vedotin to treat relapsed or refractory diffuse large B-cell lymphoma, in combination with bendamustine plus rituximab
    Amaya, M. L.
    Jimeno, A.
    Kamdar, M.
    DRUGS OF TODAY, 2020, 56 (04) : 287 - 294
12345